CSIMarket
 


Cell Medx Corp.  (CMXC)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

CMXC's Income from Cont. Operations Growth by Quarter and Year

Cell Medx.'s Income from Cont. Operations results by quarter and year




CMXC Income from Cont. Operations (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter May - -0.14 -0.24 0.39
III Quarter February - -0.39 -0.30 -0.30
II Quarter November -0.30 -0.13 -0.18 -1.06
I Quarter August -0.25 -0.24 -0.83 -0.28
FY   -0.55 -0.90 -1.55 -1.25



CMXC Income from Cont. Operations second quarter 2020 Y/Y Growth Comment
Cell Medx Corp. in the second quarter recorded loss from continued operations of $ -0.30 millions.

According to the results reported in the second quarter, Cell Medx Corp. achieved the best Income from Cont. Operations growth in Biotechnology & Drugs industry. While Cell Medx Corp.' s Income from Cont. Operations no change of % ranks overall at the positon no. in the second quarter.




CMXC Income from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter May - - - -
III Quarter February - - - -
II Quarter November - - - -
I Quarter August - - - -
FY   - - - -

Financial Statements
Cell Medx.'s second quarter 2020 Income from Cont. Operations $ -0.30 millions CMXC's Income Statement
Cell Medx.'s second quarter 2019 Income from Cont. Operations $ -0.13 millions Quarterly CMXC's Income Statement
New: More CMXC's historic Income from Cont. Operations Growth >>


CMXC Income from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter May - - - -
III Quarter February - - - -
II Quarter November - - - -
I Quarter August - - - -
FY (Year on Year)   - - - -




Income from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Cell Medx.'s Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CMXC's II. Quarter Q/Q Income from Cont. Operations Comment
Current loss from continued operations of -0.30 millions by Cell Medx Corp. appear even worse compare to the -0.25 millions loss from continued operations in the first quarter.

Within Biotechnology & Drugs industry Cell Medx Corp. achieved highest sequential Income from Cont. Operations growth. While Cell Medx.'s Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CMXC's II. Quarter Q/Q Income from Cont. Operations Comment
II. Quarter 2020 accomplishment of -0.30 millions by Cell Medx Corp. appear even less good if you take a look at -0.25 millions loss from continued operations in the first quarter.

Within Biotechnology & Drugs industry Cell Medx Corp. achieved highest sequential Income from Cont. Operations growth. While Cell Medx.'s Income from Cont. Operations growth quarter on quarter, overall rank is .


Cell Medx.'s 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Nov 30 2019)
12 Months Ending
(Aug 31 2019)
12 Months Ending
(May 31 2019)
12 Months Ending
(May 31 2018)
12 Months Ending
(Feb 28 2018)
Cumulative Income from Cont. Operations 12 Months Ending $ -1.08 $ -0.91 $ -0.91 $ -1.55 $ -0.92
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment
Cell Medx Corp.' has realized cumulative trailing twelve months loss from continued operations of $ -1 millions in the Nov 30 2019 period.
The business is getting worse as the cumulative loss from continued operations is becoming larger from $ -0.91 millions for the period from Aug 31 2019 to Feb 28 2018 and $ -0.25 millions for the twelve months ending in the quarter Feb 28 2018.

Cell Medx Corp. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment
Cell Medx Corp.' has realized cumulative trailing twelve months loss from continued operations of $ -1 millions in the Nov 30 2019 period.
The situation is worsening as the cumulative loss from continued operations is getting bigger from $ -0.91 millions for the period from Aug 31 2019 to Feb 28 2018 and $ -0.25 millions for the twelve months ending in the quarter Feb 28 2018.

Cell Medx Corp. achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Biotechnology & Drugs Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
CMXC's Income from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for CMXC's Competitors
Income from Cont. Operations Growth for Cell Medx.'s Suppliers
Income from Cont. Operations Growth for CMXC's Customers

You may also want to know
CMXC's Annual Growth Rates CMXC's Profitability Ratios CMXC's Asset Turnover Ratio CMXC's Dividend Growth
CMXC's Roe CMXC's Valuation Ratios CMXC's Financial Strength Ratios CMXC's Dividend Payout Ratio
CMXC's Roa CMXC's Inventory Turnover Ratio CMXC's Growth Rates CMXC's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Nov 30 2019 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Nov 30 2019


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

IDN's Profile

Stock Price

IDN's Financials

Business Description

Fundamentals

Charts & Quotes

IDN's News

Suppliers

IDN's Competitors

Customers & Markets

Economic Indicators

IDN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071